Gershon Fink

2.0k total citations
64 papers, 1.2k citations indexed

About

Gershon Fink is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Gershon Fink has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 19 papers in Cardiology and Cardiovascular Medicine and 14 papers in Complementary and alternative medicine. Recurrent topics in Gershon Fink's work include Cardiovascular and exercise physiology (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory Support and Mechanisms (9 papers). Gershon Fink is often cited by papers focused on Cardiovascular and exercise physiology (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory Support and Mechanisms (9 papers). Gershon Fink collaborates with scholars based in Israel, United States and Czechia. Gershon Fink's co-authors include S. Spitzer, Daniel Bendayan, Milton Sauté, Alon Yellin, Mendel Glazer, Mordechai R. Kramer, David Shitrit, Eliezer Klainman, Mordechai R. Kramer and Michael Huerta and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Hypertension.

In The Last Decade

Gershon Fink

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gershon Fink Israel 20 565 322 262 251 228 64 1.2k
Arnaud Chambellan France 17 674 1.2× 80 0.2× 54 0.2× 171 0.7× 298 1.3× 55 1.1k
Ralf Geiger Austria 16 419 0.7× 359 1.1× 40 0.2× 257 1.0× 165 0.7× 51 1.4k
Christian Tanislav Germany 23 326 0.6× 429 1.3× 53 0.2× 240 1.0× 244 1.1× 109 1.4k
Tufan Tükek Türkiye 20 145 0.3× 186 0.6× 49 0.2× 443 1.8× 123 0.5× 108 1.2k
Cécile Chenivesse France 21 460 0.8× 94 0.3× 116 0.4× 52 0.2× 319 1.4× 79 1.1k
T W Higenbottam United Kingdom 22 740 1.3× 143 0.4× 90 0.3× 188 0.7× 412 1.8× 53 1.4k
Claudio Tantucci Italy 27 1.3k 2.3× 54 0.2× 66 0.3× 226 0.9× 1.0k 4.4× 89 2.0k
Elisa Gherbesi Italy 15 143 0.3× 63 0.2× 151 0.6× 503 2.0× 130 0.6× 79 1.1k
André Luís Pereira de Albuquerque Brazil 22 909 1.6× 87 0.3× 28 0.1× 115 0.5× 270 1.2× 51 1.3k
Elveback Lr United States 20 250 0.4× 194 0.6× 82 0.3× 319 1.3× 86 0.4× 36 1.2k

Countries citing papers authored by Gershon Fink

Since Specialization
Citations

This map shows the geographic impact of Gershon Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gershon Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gershon Fink more than expected).

Fields of papers citing papers by Gershon Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gershon Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gershon Fink. The network helps show where Gershon Fink may publish in the future.

Co-authorship network of co-authors of Gershon Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Gershon Fink. A scholar is included among the top collaborators of Gershon Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gershon Fink. Gershon Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalter‐Leibovici, Ofra, Michal Benderly, Laurence S. Freedman, et al.. (2018). Disease Management plus Recommended Care versus Recommended Care Alone for Ambulatory Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 197(12). 1565–1574. 10 indexed citations
2.
Eliraz, A, et al.. (2012). Changes in daily leptin, ghrelin and adiponectin profiles following a diet with carbohydrates eaten at dinner in obese subjects. Nutrition Metabolism and Cardiovascular Diseases. 23(8). 744–750. 19 indexed citations
3.
Fridlender, Zvi G., et al.. (2012). Randomized Controlled Crossover Trial of a New Oscillatory Device as Add-On Therapy for COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 9(6). 603–610. 2 indexed citations
4.
Klainman, Eliezer, et al.. (2010). Combined Cardiopulmonary Exercise Testing and 99m TC Sestamibi Myocardial Imaging in Trained vs Untrained Patients with Coronary Artery Disease. Journal of clinical and basic cardiology. 12(1). 2–4.
5.
Klainman, Eliezer, et al.. (2008). The Funcional Effect of Beta Blockers vs Vasodilators in Hypertension Treatment. Journal of clinical and basic cardiology. 11(1). 8–10. 2 indexed citations
6.
Klainman, Eliezer, et al.. (2008). Recovery Kinetics of Oxygen Uptake in Patients with Various Degrees of Coronary Artery Disease. Journal of clinical and basic cardiology. 10(1). 16–19. 1 indexed citations
7.
Shitrit, David, et al.. (2007). Quantitative Lung Perfusion Following Single Lung Transplantation. The Thoracic and Cardiovascular Surgeon. 55(1). 48–52. 15 indexed citations
10.
Shitrit, David, et al.. (2003). Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. Transplantation Proceedings. 35(2). 627–628. 9 indexed citations
11.
Blau, Hannah, et al.. (2002). Effects of an Intensive 4-Week Summer Camp on Cystic Fibrosis. CHEST Journal. 121(4). 1117–1122. 37 indexed citations
12.
Cyjon, Arnold, M Nili, Gershon Fink, et al.. (2002). Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation. The Annals of Thoracic Surgery. 74(2). 342–347. 19 indexed citations
13.
Shitrit, David, Daniele Bendayan, Michael Huerta, et al.. (2002). Significance of a Plasma D-dimer Test in Patients with Primary Pulmonary Hypertension. CHEST Journal. 122(5). 1674–1678. 38 indexed citations
14.
Shitrit, David, Bernard Rudensky, G Izbicki, et al.. (2002). Elevation of ELISA D-Dimer Levels in Patients with Primary Pulmonary Hypertension. Respiration. 69(4). 327–329. 13 indexed citations
15.
Benbassat, Carlos, et al.. (2001). Pulmonary Function in Patients with Diabetes Mellitus. The American Journal of the Medical Sciences. 322(3). 127–132. 78 indexed citations
16.
Fink, Gershon, et al.. (1999). Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.. PubMed. 1(3). 165–8. 16 indexed citations
18.
Fink, Gershon, et al.. (1993). Assessment of exercise capacity in asthmatic children with various degrees of activity. Pediatric Pulmonology. 15(1). 41–43. 30 indexed citations
19.
Fink, Gershon, et al.. (1992). [Cardiopulmonary exercise testing in asthmatic patients].. PubMed. 122(6). 364–7, 407. 1 indexed citations
20.
Fink, Gershon, et al.. (1981). Continuous blood pressure measurement in rats with aortic baroreceptor deafferentation. American Journal of Physiology-Heart and Circulatory Physiology. 241(2). H268–H272. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026